CoChat

Variability of Insulin Absorption and Insulin Action

Heinemann, Lutz · 2002 · Diabetes Technology & Therapeutics

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Subcutaneous (s.c.) injections of identical insulin doses may lead to considerable intra- and inter-individual differences in the current metabolic control of patients with diabetes mellitus. This well-known variability of the metabolic effect of insulin hampers practical insulin therapy considerably. The aim of this review is to summarize the knowledge about this topic, with a special focus on the variability of insulin action after pulmonary administration of insulin. A number of studies have been published describing the variability of insulin absorption from the s.c. depot. Only in a few published studies has the variability of insulin action after s.c. administration been quantified. Under controlled experimental conditions s.c. injections of regular insulins result in an intra-individual coefficient of variation (CV) of 15-25% of certain pharmacodynamic summary measures--which characterize the metabolic effect of the applied insulin--in healthy subjects. The inter-individual variability was approximately 10% higher than the intra-individual variability. Subcutaneously injected intermediate- and long-acting insulin preparations were described to have an even greater variability (> 50%) than subcutaneously injected regular insulin. However, in a glucose clamp study s.c. application of NPH insulin led to an intra-individual CV in the range of 12-45% in healthy subjects. The reason for this discrepancy might be that the NPH insulin suspension was sufficiently shaken prior to drawing up the dose. Compared with conventional insulin formulations, rapid- and long-acting insulin analogues appear to have a similar variability, which means that, unfortunately, no considerable advantages in terms of variability were achieved by the invention of these novel insulin preparations. There are no appropriate studies available investigating the variability of the metabolic effect after s.c. insulin administration in patients with diabetes. The inhalation of insulin is a novel form of insulin administration that is currently under clinical development. The variability of the metabolic effect induced by the inhalation of insulin has up to now only been investigated in a small number of (published) studies. In a glucose-clamp study with healthy subjects the inhalation of an identical insulin dose on three study days led to an intra-individual variability that was comparable to that after s.c. injection of regular insulin. In a dose-response study with patients with type 1 diabetes the intra-individual CV was 34% for the area under the curve of the glucose infusion rate for 0-10 h. Studies with patients with type 2 diabetes have shown that the intra-individual CVs were within the range seen after s.c. insulin administration or even lower. In summary, the intra-individual variability of the metabolic effect observed after insulin application, be it subcutaneously injected or be it inhaled, is considerable and, therefore, hampers practical diabetes therapy. To date no means have been found that could lead to a clinically relevant reduction in the variable metabolic effect.

Overview

Integrity signals

Registry

Crossref · 10.1089/152091502320798312

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Research works printed but not linked: 6

  1. Antsiferov M, 1995, Diabetologia, 38, 733
  2. Galloway JA, 1986, Amsterdam: Excerpta Medica, 877
  3. Scholtz HE, 1999, Diabetologia, 42, A235
  4. Perea AD, 2001, Diabetologia, 44, A212
  5. Strange P, 1999, Diabetes, 8, A103
  6. Vignati L, 1995, Diabetologia, 38, 737

Cited by

See all 300

Metadata

Authors
Heinemann, L.
Affiliations
Profil Institute for Metabolic Research (DE)
Corresponding author
Heinemann, Lutz
Venue
Diabetes Technology & Therapeutics
Published
2002-10
Volume
4
Issue
5
Pages
673-682
ISSN
  • 1520-9156 (ISSN-L)
  • 1557-8593
OpenAlex
W2008449957
Cited by
267
References
26
Citations by year
2026: 9 · 2025: 10 · 2024: 6 · 2023: 12 · 2022: 12 · 2021: 12 · 2020: 10 · 2019: 7 · 2018: 9 · 2017: 15 · 2016: 6 · 2015: 17 · 2014: 11 · 2013: 6 · 2012: 21
FWCI
1.69
Type
journal article
Language
en
Open access
closed
Licence
www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
Locations
  • Diabetes Technology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
insulin action, insulin absorption, subcutaneous insulin administration, pulmonary insulin delivery, insulin analogues, NPH insulin, long-acting insulin, type 1 diabetes, type 2 diabetes, glucose clamp, coefficient of variation, interindividual variability, within-person variability, insulin pharmacodynamics, insulin therapy, dose-response relationship, glycemic control
MeSH terms
Administration, Inhalation, Blood Glucose, Diabetes Mellitus, Humans, Injections, Subcutaneous, Insulin, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Variability of Insulin Absorption and Insulin Action. https://app.cochat.ai/papers/10.1089/152091502320798312
The paper
Heinemann, L. (2002). Variability of Insulin Absorption and Insulin Action. Diabetes Technology & Therapeutics. https://doi.org/10.1089/152091502320798312

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.